|
ASH1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6278089987054E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23245857963639E-12 |
| Normal-vs-Stage2 |
1.97219999997778E-07 |
| Normal-vs-Stage3 |
1.5514034501507E-11 |
| Normal-vs-Stage4 |
3.6924000523797E-09 |
| Stage1-vs-Stage2 |
7.703400E-01 |
| Stage1-vs-Stage3 |
4.779800E-01 |
| Stage1-vs-Stage4 |
4.210200E-01 |
| Stage2-vs-Stage3 |
8.349200E-01 |
| Stage2-vs-Stage4 |
6.925600E-01 |
| Stage3-vs-Stage4 |
7.948200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48689957516035E-14 |
| Normal-vs-AfricanAmerican |
5.544000E-03 |
| Normal-vs-Asian |
6.86720003084673E-09 |
| Caucasian-vs-AfricanAmerican |
4.957900E-02 |
| Caucasian-vs-Asian |
7.661800E-01 |
| AfricanAmerican-vs-Asian |
4.279900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.86969995041864E-10 |
| Normal-vs-Female |
1.90769622321341E-12 |
| Male-vs-Female |
2.267600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.35780284185694E-11 |
| Normal-vs-Age(41-60Yrs) |
5.37969668812366E-12 |
| Normal-vs-Age(61-80Yrs) |
2.52559972935273E-10 |
| Normal-vs-Age(81-100Yrs) |
4.048600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.581600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.547000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.306000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.702400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.641200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.831200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.537900E-03 |
| Classical-VS-Follicular |
1.420190E-02 |
| Classical-VS-Other |
1.752570E-01 |
| Classical-VS-Normal |
4.63799999517178E-08 |
| Tall-VS-Follicular |
5.578200E-01 |
| Tall-VS-Other |
7.444800E-01 |
| Tall-VS-Normal |
1.90940041555621E-10 |
| Follicular-VS-Other |
6.206200E-01 |
| Follicular-VS-Normal |
3.49329454252256E-11 |
| Other-VS-Normal |
1.060790E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.80597808613948E-13 |
| Normal-vs-N1 |
8.07459987761661E-10 |
| N0-vs-N1 |
4.120000E-01 |
|
|
